Abstract
This paper describes methods of determining costs for economic evaluations of healthcare and considers how cost determination is being affected by recent developments in healthcare. The literature was reviewed to identify the strengths and weaknesses of the four principal methods of cost determination: micro-costing, activity-based costing, charge-based costing, and gross costing. A scoping review was conducted to identify key trends in healthcare delivery and to identify costing issues associated with these changes. Existing guidelines provide information on how to implement various costing methods. Bottom-up costing is needed when accuracy is paramount, but top-down approaches are often the only feasible approach. We describe six healthcare trends that have important implications for costing methodology: (1) reform in payment mechanisms; (2) care delivery in less restrictive settings; (3) the growth of telehealth interventions; (4) the proliferation of new technology; (5) patient privacy concerns; and (6) growing efforts to implement guidelines. Some costs are difficult to measure and have been overlooked. These include physician services for inpatients, facility costs for outpatient services, the cost of developing treatment innovations, patient and caregiver costs, and the indirect costs of organizational interventions. Standardized methods are needed to determine social welfare and productivity costs. In the future, cost determination will be facilitated by technological advances but hindered by the shift to capitated payment, to the provision of care in less restrictive settings, and by heightened concern for medical record privacy.
Similar content being viewed by others
References
Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.
Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005.
Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, et al. Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices–budget impact analysis. Value Health. 2007;10(5):336–47.
Adam T, Koopmanschap MA, Evans DB. Cost-effectiveness analysis: can we reduce variability in costing methods? Int J Technol Assess Health Care. 2003;19(2):407–20.
Smith MW, Barnett PG. Direct measurement of health care costs. Med Care Res Rev. 2003;60(3 Suppl):74S–91S.
Findorff MJ, Wyman JF, Croghan CF, Nyman JA. Use of time studies for determining intervention costs. Nurs Res. 2005;54(4):280–4 (pii:00006199-200507000-00011).
Johnston K, Buxton MJ, Jones DR, Fitzpatrick R. Assessing the costs of healthcare technologies in clinical trials. Health Technol Assess. 1999;3(6):1–76.
Frick KD. Microcosting quantity data collection methods. Med Care. 2009;47(7 Suppl 1):S76–81. doi:10.1097/MLR.0b013e31819bc064.
Xu X, Grossetta Nardini HK, Ruger JP. Micro-costing studies in the health and medical literature: protocol for a systematic review. Syst Rev. 2014;3:47. doi:10.1186/2046-4053-3-47.
Azoulay A, Doris NM, Filion KB, Caron J, Pilote L, Eisenberg MJ. The use of the transition cost accounting system in health services research. Cost Eff Resour Alloc. 2007;5:11. doi:10.1186/1478-7547-5-11.
Ross TK. Analyzing health care operations using ABC. J Health Care Finance. 2004;30(3):1–20.
Udpa S. Activity-based costing for hospitals. Health Care Manag Rev. 1996;21(3):83–96.
Kaplan RS, Anderson SR. Time-driven activity-based costing. Harv Bus Rev. 2004;82(11):131–8, 50.
Udpa S. Activity cost analysis: a tool to cost medical services and improve quality of care. Manag Care Q. 2001;9(3):34–41.
Young DW. The folly of using RCCs and RVUs for intermediate product costing. Healthc Financ Manag. 2007;61(4):100–6, 8.
Kaplan RS, Witkowski M, Abbott M, Guzman AB, Higgins LD, Meara JG, et al. Using time-driven activity-based costing to identify value improvement opportunities in healthcare. J Healthc Manag. 2014;59(6):399–412.
Hunkeler EM, Hung YY, Rice DP, Weisner C, Hu T. Alcohol consumption patterns and health care costs in an HMO. Drug Alcohol Depend. 2001;64(2):181–90 (pii:S0376871601001193).
Parthasarathy S, Mertens J, Moore C, Weisner C. Utilization and cost impact of integrating substance abuse treatment and primary care. Med Care. 2003;41(3):357–67. doi:10.1097/01.MLR.0000053018.20700.56.
Barnett PG, Rodgers JH. Use of the Decision Support System for VA cost-effectiveness research. Med Care. 1999;37(4 Suppl Va):AS63–70.
Hill NT, Johns EL. Adoption of costing systems by U.S. hospitals. Hosp Health Serv Adm. 1994;39(4):521–37.
Gehlert E, Jacobs JC, Barnett PG. Technical Report 32: costing methods used in VA research, 1980–2012. Menlo Park: VA Palo Alto, Health Economics Resource Center; 2016.
Taira DA, Seto TB, Siegrist R, Cosgrove R, Berezin R, Cohen DJ. Comparison of analytic approaches for the economic evaluation of new technologies alongside multicenter clinical trials. Am Heart J. 2003;145(3):452–8.
Finkler SA. The distinction between cost and charges. Ann Intern Med. 1982;96(1):102–9.
Riley GF. Administrative and claims records as sources of health care cost data. Med Care. 2009; 47(7 Suppl 1):S51–55.
Centers for Medicare and Medicaid Services. Historical impact files for FY 1994 through present. Baltimore: CMS; 2012. https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/Historical-Impact-Files-for-FY-1994-through-Present.html. Accessed 21 May 2016.
Shwartz M, Young DW, Siegrist R. The ratio of costs to charges: how good a basis for estimating costs? Inquiry. 1995;32(4):476–81.
Phibbs CS, Bhandari A, Yu W, Barnett PG. Estimating the costs of VA ambulatory care. Med Care Res Rev. 2003;60(3 Suppl):54S–73S.
Peterson C, Xu L, Florence C, Grosse SD, Annest JL. Professional fee ratios for US hospital discharge data. Med Care. 2015;53(10):840–9. doi:10.1097/MLR.0000000000000410.
Bhandari A, Wagner T. Self-reported utilization of health care services: improving measurement and accuracy. Med Care Res Rev. 2006;63(2):217–35. doi:10.1177/1077558705285298.
Barnett PG. Research without billing data. Econometric estimation of patient-specific costs. Med Care. 1997;35(6):553–63.
Tan SS, Rutten FF, van Ineveld BM, Redekop WK, Hakkaart-van Roijen L. Comparing methodologies for the cost estimation of hospital services. Eur J Health Econ. 2009;10(1):39–45. doi:10.1007/s10198-008-0101-x.
Chapko MK, Liu CF, Perkins M, Li YF, Fortney JC, Maciejewski ML. Equivalence of two healthcare costing methods: bottom-up and top-down. Health Econ. 2009;18(10):1188–201. doi:10.1002/hec.1422.
Hardy KM, Kwong J, Pitzul KB, Vergis AS, Jackson TD, Urbach DR, et al. A cost comparison of laparoscopic and open colon surgery in a publicly funded academic institution. Surg Endosc. 2014;28(4):1213–22. doi:10.1007/s00464-013-3311-y.
Cooper R, Kramer TR. Revenue-based cost assignment: a potent but hidden threat to the survival of the multispecialty medical practice. Acad Med. 2010;85(3):538–47. doi:10.1097/ACM.0b013e3181cd4cf7.
Olsson TM. Comparing top-down and bottom-up costing approaches for economic evaluation within social welfare. Eur J Health Econ. 2011;12(5):9.
Mogyorosy Z, Smith P. The main methodological issues in costing health care services: a literature review. York: University of York, Center for Health Economics; 2005.
Tarricone R. Cost-of-illness analysis. What room in health economics? Health Policy. 2006;77(1):51–63. doi:10.1016/j.healthpol.2005.07.016.
Rice DP. Estimating the cost of illness. Am J Public Health Nations Health. 1967;57(3):424–40.
Institute ECRI. Agency for Healthcare Research and Quality Healthcare Horizon Scanning System: Horizon Scanning Protocol and Operations Manual. Rockville: AHRQ; 2015.
Centers for Medicare & Medicaid Services. Better care. Smarter spending. Healthier people: paying providers for value, not volume. Fact Sheets. Baltimore: CMS; 2015. https://www.cms.gov/Newsroom/MediaReleaseDatabase/Fact-sheets/2015-Fact-sheets-items/2015-01-26-3.html. Accessed 12 Apr 2015.
Struijs JN, Mohnen SM, Molema CCM, de Jong-VanTil JT, Baan CA. Effects of bundled payment on curative health care costs in the Netherlands: an analysis for diabetes care and vascular risk management based on nationwide claim data, 2007–2010. Bilthoven: National Institute for Public Health and the Environment; 2012.
Lix LM, Yao X, Kephart G, Quan H, Smith M, Kuwornu JP, et al. A prediction model to estimate completeness of electronic physician claims databases. BMJ Open. 2015;5(e006858):8. doi:10.1136/bmjopen-2014-006858.
Alshammari AM, Hux JE. The impact of non-fee-for-service reimbursement on chronic disease surveillance using administrative data. Can J Public Health. 2009;100(6):3.
Akhavan S, Ward L, Bozic KJ. Time-driven activity-based costing more accurately reflects costs in arthroplasty surgery. Clin Orthop Relat Res. 2016;474(1):8–15. doi:10.1007/s11999-015-4214-0.
Hilsenrath P, Eakin C, Fischer K. Price-transparency and cost accounting: challenges for health care organizations in the consumer-driven era. Inquiry. 2015;52. doi:10.1177/0046958015574981.
Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. Vital Health Stat 13. 2011;(169):1–38.
Eiken S, Sredl K, Burwell B, Saucier P. Medicaid expenditures for long-term services and supports (LTSS) in FY 2013: home and community-based services were a majority of LTSS spending. Washington, DC: Medicaid.gov; 2015.
Rawson JV, Kassing P. HOPPS: evolution of a CMS process. J Am Coll Radiol. 2007;4(2):102–5. doi:10.1016/j.jacr.2006.09.002.
He D, Mellor JM. Medicare payment and hospital provision of outpatient care to the uninsured. Health Serv Res. 2016;51(4):1388–406. doi:10.1111/1475-6773.12433.
Centers for Medicare & Medicaid Services. Hospital Outpatient PPS. Baltimore, MD: CMS; 2016. https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/HospitalOutpatientPPS/. Accessed 15 Aug 2016.
He D, Mellor JM. Hospital volume responses to Medicare’s outpatient prospective payment system: evidence from Florida. J Health Econ. 2012;31(5):730–43. doi:10.1016/j.jhealeco.2012.06.001.
McCaffrey N, Cassel JB, Coast J. Bringing the economic cost of informal caregiving into focus. Palliat Med. 2015;29(10):866–7. doi:10.1177/0269216315612653.
Tan SS, Bouwmans CA, Rutten FF, Hakkaart-van Roijen L. Update of the Dutch manual for costing in economic evaluations. Int J Technol Assess Health Care. 2012;28(2):152–8. doi:10.1017/S0266462312000062.
Goodrich K, Kaambwa B, Al-Janabi H. The inclusion of informal care in applied economic evaluation: a review. Value Health. 2012;15(6):975–81. doi:10.1016/j.jval.2012.05.009.
Zhang W, Bansback N, Anis AH. Measuring and valuing productivity loss due to poor health: a critical review. Soc Sci Med. 2011;72(2):185–92. doi:10.1016/j.socscimed.2010.10.026.
Koopmanschap MA, van Exel JN, van den Berg B, Brouwer WB. An overview of methods and applications to value informal care in economic evaluations of healthcare. Pharmacoeconomics. 2008;26(4):269–80.
Russell LB. Completing costs: patients’ time. Med Care. 2009;47(7 Suppl 1):S89–93. doi:10.1097/MLR.0b013e31819bc077.
Bergmo TS. How to measure costs and benefits of eHealth interventions: an overview of methods and frameworks. J Med Internet Res. 2015;17(11):e254. doi:10.2196/jmir.4521.
Mistry H, Garnvwa H, Oppong R. Critical appraisal of published systematic reviews assessing the cost-effectiveness of telemedicine studies. Telemed J E Health. 2014;20(7):609–18. doi:10.1089/tmj.2013.0259.
Wade VA, Karnon J, Elshaug AG, Hiller JE. A systematic review of economic analyses of telehealth services using real time video communication. BMC Health Serv Res. 2010;10:233. doi:10.1186/1472-6963-10-233.
Bergmo TS. Can economic evaluation in telemedicine be trusted? A systematic review of the literature. Cost Eff Resour Alloc. 2009;7:18. doi:10.1186/1478-7547-7-18.
Reardon T. Research findings and strategies for assessing telemedicine costs. Telemed J E Health. 2005;11(3):348–69. doi:10.1089/tmj.2005.11.348.
Baker TB, Gustafson DH, Shah D. How can research keep up with eHealth? Ten strategies for increasing the timeliness and usefulness of eHealth research. J Med Internet Res. 2014;16(2):e36. doi:10.2196/jmir.2925.
Hoyle M, Anderson R. Whose costs and benefits? Why economic evaluations should simulate both prevalent and all future incident patient cohorts. Med Decis Mak. 2010;30(4):426–37. doi:10.1177/0272989X09353946.
Hoyle M. Accounting for the drug life cycle and future drug prices in cost-effectiveness analysis. Pharmacoeconomics. 2011;29(1):1–15. doi:10.2165/11584230-000000000-00000.
Kulynych J, Korn D. The effect of the new federal medical-privacy rule on research. N Engl J Med. 2002;346(3):201–4. doi:10.1056/NEJM200201173460312346/3/201.
Gunn PP, Fremont AM, Bottrell M, Shugarman LR, Galegher J, Bikson T. The health insurance portability and accountability act privacy rule: a practical guide for researchers. Med Care. 2004;42(4):321–7 (pii:00005650-200404000-00004).
Shen JJ, Samson LF, Washington EL, Johnson P, Edwards C, Malone A. Barriers of HIPAA regulation to implementation of health services research. J Med Syst. 2006;30(1):65–9.
Hussey PS, Anderson GF, Osborn R, Feek C, McLaughlin V, Millar J, et al. How does the quality of care compare in five countries? Health Aff (Millwood). 2004;23(3):89–99.
McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, et al. The quality of health care delivered to adults in the United States. N Engl J Med. 2003;348(26):2635–45. doi:10.1056/NEJMsa022615.
Morris ZS, Wooding S, Grant J. The answer is 17 years, what is the question: understanding time lags in translational research. J R Soc Med. 2011;104(12):510–20. doi:10.1258/jrsm.2011.110180.
Principal Investigators CTSA, Shamoon H, Center D, Davis P, Tuchman M, Ginsberg H, et al. Preparedness of the CTSA’s structural and scientific assets to support the mission of the National Center for Advancing Translational Sciences (NCATS). Clin Transl Sci. 2012;5(2):121–9. doi:10.1111/j.1752-8062.2012.00401.x.
Demakis JG, McQueen L, Kizer KW, Feussner JR. Quality Enhancement Research Initiative (QUERI): a collaboration between research and clinical practice. Med Care. 2000;38(6 Suppl 1):I17–25.
Hoomans T, Evers SM, Ament AJ, Hubben MW, van der Weijden T, Grimshaw JM, et al. The methodological quality of economic evaluations of guideline implementation into clinical practice: a systematic review of empiric studies. Value Health. 2007;10(4):305–16. doi:10.1111/j.1524-4733.2007.00175.x.
Vale L, Thomas R, MacLennan G, Grimshaw J. Systematic review of economic evaluations and cost analyses of guideline implementation strategies. Eur J Health Econ. 2007;8(2):111–21. doi:10.1007/s10198-007-0043-8.
Severens JL. Value for money of changing healthcare services? Economic evaluation of quality improvement. Qual Saf Health Care. 2003;12(5):366–71.
Fortney JC, Pyne JM, Burgess JF Jr. Population-level cost-effectiveness of implementing evidence-based practices into routine care. Health Serv Res. 2014;49(6):1832–51. doi:10.1111/1475-6773.12247.
Liu CF, Rubenstein LV, Kirchner JE, Fortney JC, Perkins MW, Ober SK, et al. Organizational cost of quality improvement for depression care. Health Serv Res. 2009;44(1):225–44. doi:10.1111/j.1475-6773.2008.00911.x.
Sathe NA, Nocon RS, Hughes B, Peek ME, Chin MH, Huang ES. The costs of participating in a diabetes quality improvement collaborative: variation among five clinics. Jt Comm J Qual Patient Saf. 2016;42(1):18–25.
Mason J, Freemantle N, Nazareth I, Eccles M, Haines A, Drummond M. When is it cost-effective to change the behavior of health professionals? JAMA. 2001;286(23):2988–92 (pii:jsc10303).
Centers for Medicare & Medicaid Services. National Health Expenditures 2014 Highlights. 2015. https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/highlights.pdf. Accessed 19 May 2016.
Author contributions
JJ and PB both contributed to the conceptualization, literature search, synthesis and drafting of the paper. Both authors act as the guarantor for this work.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
JJ and PB declare have no conflicts of interest. This research was supported by the US Department of Veterans Affairs Health Services Research and Development Service (ECN-99-017-16S2).
Rights and permissions
About this article
Cite this article
Jacobs, J.C., Barnett, P.G. Emergent Challenges in Determining Costs for Economic Evaluations. PharmacoEconomics 35, 129–139 (2017). https://doi.org/10.1007/s40273-016-0465-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40273-016-0465-1